HOUSTON, TX / ACCESSWIRE / June 6, 2022 / Vertex Energy, Inc. (NASDAQ:VTNR) ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, today announced it ...

Vertex saw disappointments in 2022, that may be about to change. Profitability may improve as onerous hedging rolled off for Q4. Shares could double from here to around $18 on my estimates (range: $10 ...

Now in its eighth year, Built In’s Best Places to Work program celebrates the companies shaping the future of work. In a rapidly evolving AI-first job market, recognition as a Best Place to Work helps ...

The US Food and Drug Administration (FDA) has accepted Vertex Pharmaceuticals’ completed new drug application (NDA) submission for suzetrigine, as the company’s non-opioid-based treatment for acute ...

On Monday, Goldman Sachs reaffirmed a Buy rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX), with a set price target of $598.00. At a recent event, Vertex presented ...

Google Cloud this week introduced Vertex AI Agent Builder, a new tool that consolidates Vertex AI Search and Conversation products, enhancing the developer's toolbox for generative AI agent ...

BEIJING/HONG KONG, Oct 18 (Reuters) - Venture capital firm Vertex Ventures, backed by Singapore state investor Temasek, is set to raise nearly $500 million for a new fund that will invest in efforts ...

BEIJING/HONG KONG - Venture capital firm Vertex Ventures, backed by Singapore state investor Temasek, is set to raise nearly $500 million for a new fund that will invest in efforts to step up China's ...